Dermal Fillers
REVANESSE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 11118
Revanesse Lips™+
In stock
Volume
2 x 1,2 mL
Laboratory
Prollenium Medical Technologies Inc.
Origin
Canada
Indication
Lip volume restoration
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Revanesse Lips+ is a biocompatible, biodegradable, non-pyrogenic, sterile, injectable viscoelastic clear colourless hydrogel from Prollenium Medical Technologies in Aurora, Canada. It is based on bioresorbable BDDE cross-linked hyaluronic acid at 25 mg/mL containing 0.3% lidocaine, the hyaluronic acid produced by the Streptococcus species of bacteria. It is indicated for submucosal implantation for lip augmentation in patients 22 years of age or older, and is FDA approved under PMA P160042/S010. Each box contains two 1.2 mL glass syringes with two 0.5 inch 30-gauge sterile needles.
Key Benefits of Revanesse Lips™+
- BDDE cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
- Indicated specifically for lip augmentation by submucosal implantation
- FDA approved under PMA P160042/S010
- Supplied with two 0.5 inch 30-gauge sterile needles, the finest gauge in the range
- Supplied as two 1.2 mL glass syringes per box
- Hyaluronic acid produced by the Streptococcus species of bacteria
- Removable label portion for the patient record
Indications and Professional Use
Main indications
- Lip augmentation by submucosal implantation
Professional use
For professional use. Revanesse Lips+ is administered by qualified physicians trained in the proper injection technique, and is not for retail sale or self-administration. It is placed by submucosal implantation in the lip using the 0.5 inch 30-gauge needles supplied. Its approval was supported by two clinical studies: a multicentre, double-blind, randomised, controlled treatment study enrolling 158 subjects over 10 months, and a multicentre, open-label retreatment study of 84 of those subjects over a further 8 months, with lip fullness assessed on the 5-point Lip Fullness Grading Scale.
Treatment areas
- Lips
Patient profile
Indicated for patients 22 years of age or older seeking lip augmentation. It must not be used in patients who develop hypertrophic scarring or keloid formation, in patients with evidence of scars at the intended treatment sites, in patients with acne or other inflammatory skin disease, in patients with multiple severe allergies or a history of allergy, or in patients with unattainable expectations. It must never be used in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion treatments, or with over-the-counter or prescription wrinkle treatments within 4 weeks of treatment.
How Revanesse Lips™+ Works
Lips+ is placed submucosally in the lip, where the cross-linked hyaluronic acid hydrogel adds volume directly. It is the only reference in the Revanesse range with an indication written specifically and solely for lip augmentation, which is reflected in its delivery: a fine 0.5 inch 30-gauge needle rather than the 27G used by the deeper-placed grades. The 0.3% lidocaine is present for injection comfort. Each syringe carries a removable portion of its label that can be affixed to the patient record for traceability.
Why Order From Allpara
Allpara offers genuine, verified REVANESSE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Lips+ differ from the other Revanesse references?
Its indication is written solely for lip augmentation, by submucosal implantation, in patients 22 years of age or older. It shares the 25 mg/mL BDDE cross-linked hyaluronic acid and 0.3% lidocaine of Contour+ and Sculpt+, but is supplied with finer 0.5 inch 30-gauge needles rather than 27G.
What clinical evidence supports Revanesse Lips+?
Two studies formed the basis of the PMA approval decision: a multicentre, double-blind, randomised, controlled treatment study of 158 subjects lasting 10 months, and a multicentre, open-label retreatment study of 84 of those subjects lasting a further 8 months. Effectiveness was measured as change in overall Lip Fullness Grading Scale score for both lips together.
Where can clinics buy Revanesse Lips+?
ALLPARA supplies Revanesse Lips+ to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.
More from Prollenium Medical Technologies
Clinic alternatives
/ Recently viewed
Pick up where you left off
Revanesse Lips™+
In stock
CE Marked
Revanesse Lips+ is a biocompatible, biodegradable, non-pyrogenic, sterile, injectable viscoelastic clear colourless hydrogel from Prollenium Medical Technologies in Aurora, Canada. It is based on bioresorbable BDDE cross-linked hyaluronic acid at 25 mg/mL containing 0.3% lidocaine, the hyaluronic acid produced by the Streptococcus species of bacteria. It is indicated for submucosal implantation for lip augmentation in patients 22 years of age or older, and is FDA approved under PMA P160042/S010. Each box contains two 1.2 mL glass syringes with two 0.5 inch 30-gauge sterile needles.
Key Benefits of Revanesse Lips™+
- BDDE cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
- Indicated specifically for lip augmentation by submucosal implantation
- FDA approved under PMA P160042/S010
- Supplied with two 0.5 inch 30-gauge sterile needles, the finest gauge in the range
- Supplied as two 1.2 mL glass syringes per box
- Hyaluronic acid produced by the Streptococcus species of bacteria
- Removable label portion for the patient record
Indications and Professional Use
Main indications
- Lip augmentation by submucosal implantation
Professional use
For professional use. Revanesse Lips+ is administered by qualified physicians trained in the proper injection technique, and is not for retail sale or self-administration. It is placed by submucosal implantation in the lip using the 0.5 inch 30-gauge needles supplied. Its approval was supported by two clinical studies: a multicentre, double-blind, randomised, controlled treatment study enrolling 158 subjects over 10 months, and a multicentre, open-label retreatment study of 84 of those subjects over a further 8 months, with lip fullness assessed on the 5-point Lip Fullness Grading Scale.
Treatment areas
- Lips
Patient profile
Indicated for patients 22 years of age or older seeking lip augmentation. It must not be used in patients who develop hypertrophic scarring or keloid formation, in patients with evidence of scars at the intended treatment sites, in patients with acne or other inflammatory skin disease, in patients with multiple severe allergies or a history of allergy, or in patients with unattainable expectations. It must never be used in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion treatments, or with over-the-counter or prescription wrinkle treatments within 4 weeks of treatment.
How Revanesse Lips™+ Works
Lips+ is placed submucosally in the lip, where the cross-linked hyaluronic acid hydrogel adds volume directly. It is the only reference in the Revanesse range with an indication written specifically and solely for lip augmentation, which is reflected in its delivery: a fine 0.5 inch 30-gauge needle rather than the 27G used by the deeper-placed grades. The 0.3% lidocaine is present for injection comfort. Each syringe carries a removable portion of its label that can be affixed to the patient record for traceability.
Why Order From Allpara
Allpara offers genuine, verified REVANESSE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Lips+ differ from the other Revanesse references?
Its indication is written solely for lip augmentation, by submucosal implantation, in patients 22 years of age or older. It shares the 25 mg/mL BDDE cross-linked hyaluronic acid and 0.3% lidocaine of Contour+ and Sculpt+, but is supplied with finer 0.5 inch 30-gauge needles rather than 27G.
What clinical evidence supports Revanesse Lips+?
Two studies formed the basis of the PMA approval decision: a multicentre, double-blind, randomised, controlled treatment study of 158 subjects lasting 10 months, and a multicentre, open-label retreatment study of 84 of those subjects lasting a further 8 months. Effectiveness was measured as change in overall Lip Fullness Grading Scale score for both lips together.
Where can clinics buy Revanesse Lips+?
ALLPARA supplies Revanesse Lips+ to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.
More from Prollenium Medical Technologies
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.